Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Atrial fibrillation: diagnosis and management

NICE guideline
Reference number: NG196
Published: 27 April 2021
Last updated: 30 June 2021

History

Stakeholder list updated

Stakeholder list (PDF 124 KB)

Published:

20 May 2022

Guidance published

Committee member list (PDF 134 KB)

Published:

27 April 2021
Equality impact assessment - section 4 (PDF 135 KB)

Published:

27 April 2021
Consultation comments and responses (PDF 3.44 MB)

Published:

29 July 2022

Equality and health inequalities assessment

Equality impact assessment - Section 1 (PDF 213 KB)

Published:

13 June 2018
Equality impact assessment - Section 2 (PDF 228 KB)

Published:

28 November 2018
Equality impact assessment - Section 3 (PDF 136 KB)

Published:

22 September 2020

Draft guidance consultation

Draft guidance consultation
Comments form (MSWord 37 KB)

Published:

23 September 2020
Committee member list (PDF 134 KB)

Published:

23 September 2020
Evidence review A: Effectiveness of tests for detection (PDF 2.3 MB)

Published:

23 September 2020
Evidence review B: Accuracy of tests for detection (PDF 4.86 MB)

Published:

23 September 2020
Evidence review C&D: Tools to predict stroke in people with atrial fibrillation (PDF 4.15 MB)

Published:

23 September 2020
Evidence review E&F: Risk stratification tools for predicting bleeding in people with atrial fibrillation (PDF 7.52 MB)

Published:

23 September 2020
Evidence review G1: Anticoagulant therapy for stroke prevention in people with atrial fibrillation (PDF 5.02 MB)

Published:

23 September 2020
Evidence review G2: Anticoagulant therapy: health economics analysis (PDF 11.95 MB)

Published:

23 September 2020
Evidence review H: Discontinuing anticoagulation in people whose atrial fibrillation has resolved (PDF 1.09 MB)

Published:

23 September 2020
Evidence review I: Non-ablative rate control therapies (PDF 1.42 MB)

Published:

23 September 2020
Evidence review J1: Ablation (PDF 6.02 MB)

Published:

23 September 2020
Evidence review J2: Ablation: network meta-analysis (PDF 1.53 MB)

Published:

23 September 2020
Evidence review J3: Ablation: health economics analysis (PDF 3.37 MB)

Published:

23 September 2020
Evidence review K: Antiarrhythmic drugs after ablation (PDF 1.57 MB)

Published:

23 September 2020
Evidence review L: Treatment strategies for atrial fibrillation after cardiothoracic surgery (PDF 2.67 MB)

Published:

23 September 2020
Evidence review M: Statins for preventing atrial fibrillation after cardiothoracic surgery (PDF 1.81 MB)

Published:

23 September 2020
Short version of draft guideline (PDF 558 KB)

Published:

23 September 2020
Addendum appendix - Method (PDF 1.35 MB)

Published:

23 September 2020
Addendum appendix - Acknowledgements (PDF 230 KB)

Published:

23 September 2020
Addendum appendix - Algorithm (PDF 141 KB)

Published:

23 September 2020

Pre-consultation documents released

Economic plan (PDF 106 KB)

Published:

05 February 2020
Search strategies (PDF 4.51 MB)

Published:

05 February 2020
Review questions (PDF 174 KB)

Published:

05 February 2020

Committee list updated

Committee member list (PDF 121 KB)

Published:

07 February 2020

Scope published

Consultation comments and responses (PDF 1.52 MB)

Published:

27 November 2018
Final scope (PDF 298 KB)

Published:

28 November 2018

Committee meetings

Committee meeting
Minutes - GC1 (PDF 225 KB)

Published:

26 October 2018
Minutes - GC2 (PDF 182 KB)

Published:

28 November 2018
Minutes - GC3 (PDF 95 KB)

Published:

11 January 2019
Minutes - GC4 (PDF 53 KB)

Published:

18 February 2019
Minutes - GC5 (PDF 216 KB)

Published:

01 April 2019
Minutes - GC6 (PDF 229 KB)

Published:

13 May 2019
Minutes - GC7 (PDF 93 KB)

Published:

24 June 2019
Minutes - GC9 (PDF 175 KB)

Published:

15 October 2019
Minutes - GC10 (PDF 92 KB)

Published:

21 November 2019
Minutes - GC11 (PDF 93 KB)

Published:

22 November 2019
Minutes - GC12 (PDF 116 KB)

Published:

08 January 2020
Minutes - GC13 (PDF 106 KB)

Published:

27 July 2020
Minutes GC8 (PDF 129 KB)

Published:

10 September 2019
Minutes -GC14 (PDF 112 KB)

Published:

23 November 2020

Draft scope consultation

Draft scope consultation
Comments form (MSWord 63 KB)

Published:

13 June 2018
Draft scope (PDF 346 KB)

Published:

13 June 2018
Stakeholder list (PDF 40 KB)

Published:

13 June 2018